Fifty top lawyers of major corporations, including Big Pharma, Big Insurance and Big Tech, are urging the federal court system to clarify a rule of evidence that sets standards on expert testimony.

The lawyers, primarily chief legal officers and general counsel, sent a joint letter Monday to the Advisory Committee on Evidence Rules, which is looking at how federal courts address expert testimony and is exploring whether to amend the procedural rule, known as Rule 702.